TipRanks
Active Biotech AB (DE:BTP)
FRANKFURT:BTP
Germany Market

Active Biotech AB (BTP) Stock News & Sentiment

0 Followers
Active Biotech Wins Japanese Patent for Laquinimod Eye Treatment, Bolstering Global IP Strategy
Premium
Company Announcements
Active Biotech Wins Japanese Patent for Laquinimod Eye Treatment, Bolstering Global IP Strategy
12d ago
Active Biotech Deepens U.S. Ties to Advance Tasquinimod in Myelofibrosis
Premium
Company Announcements
Active Biotech Deepens U.S. Ties to Advance Tasquinimod in Myelofibrosis
2M ago
Active Biotech Starts Dosing in Amended Tasquinimod Myelofibrosis Trial
Premium
Company Announcements
Active Biotech Starts Dosing in Amended Tasquinimod Myelofibrosis Trial
3M ago

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0.25 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:BTP’s Media Buzz Sentiment?
Currently, no data Available
What is DE:BTP’s weekly average amount of articles?
In an average week, 0.25 articles about DE:BTP are published.
    What is DE:BTP’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    AMGNAmgen
    GKOSGlaukos
    OVIDOvid Therapeutics
    ABTAbbott Laboratories
    IQVIQVIA Holdings
    Showing the stocks with the most bullish news sentiment over the past week